Executive Vice President, Chief Financial Officer

Executive Vice President, Head of Development

Biogen chair Caroline Dorsa to retire, Maria Freire to succeed

SC Leqembi lands priority review in China

Biogen Hits 52-Week High, Alzheimer's Drug Sales Jump

Biogen pins SMA recovery on high-dose Spinraza amid projected 2026 revenue slump

Senior Clinical Development Lead, Immunology

Biogen is a mid-sized biotechnology company focused on transforming the lives of patients with severe immune-mediated diseases. The Senior Clinical Development Lead will lead the development of early-phase immunology programs and indication expansion opportunities, driving high-priority clinical programs across all stages of development.

Senior Clinical Development Lead, Immunology and Indication Expansion, WCH

Chief Operating Officer

Associate Director Regulatory Affairs Labeling

argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline

Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today

OMG—argenx scores again with Vyvgart in ocular myasthenia gravis

argenX’s Vyvgart holds potential to break into ocular myasthenia gravis market, says GlobalData

0.4444444477558136

Clinical Development Indication Lead - Rheumatology

argenx is a biotech company transforming immunology and delivering medicines for autoimmune patients. The Clinical Development Indication Lead will lead the clinical team for a specific indication, developing and managing the Clinical Development Plan while ensuring high-quality medical support and compliance throughout the studies.

Senior Clinical Development Lead, Immunology And Indication Expansion, Wch

Senior Clinical Development Lead, Immunology And Indication Expansion, Wch in united states (1000+)

Senior Clinical Development Lead, Immunology and Indication Expansion, WCH

Clinical Development Indication Lead - Rheumatology